DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Precise-engineering of monodisperse magnetite nanoparticles with low-level of cobalt doping for enhanced MRI contrast performance
Herein, we designed and synthesized cobalt-modified magnetite nanoparticles (MNPs) in an environmentally safe aqueous medium by using biocompatible Pluronic F127 as dispersant without altering the Fe3+/Fe2+ stoichiometric ratio of 2:1. Gradually increasing amounts of cobalt (1, 5, 10 mol %) were added to this formulation. The obtained MNPs were systematically characterized for their physico-chemical and magnetic properties by ICP-OES, XRD, TEM/EDX, FT-IR, RAMAN, XPS, DLS, Zeta potential, and VSM. Our method ensured that iron oxidation states and their stoichiometry remain unchanged while incorporation of Co was successfully achieved with Co2+ as the oxidation state, according to XPS. XRD confirmed the inverse spinel structure with cobalt ions mainly occupying the interstitial sites although RAMAN revealed a slight contribution of normal spinel. TEM revealed nanoparticles of ∼ 11.8 nm, displaying a mixed sphere- and cubic-like morphology while DLS and Zeta showed some Co-induced agglomeration and a shift toward positive values, respectively. In vitro cytotoxicity tests indicated good preliminary biocompatibility for all samples. Co-modified MNPs showed enhanced r2 values in agarose phantoms on 1T MRI apparatus. These outcomes obviously indicate that cobalt-modified magnetite have promising practical implications, being suitable for cancer diagnosis and recommending further in vivo evaluation (e.g, toxicity, biodistribution, immune-response studies)., This work was supported by two grants: H2020 grant – ERA-Chair, no. 952390/2020 and one of the Romanian Ministry of Research, Innovation and Digitalization, CNCS - UEFISCDI, PN-III-P3-3.6-H2020-2020-0105, no. 35/2021. R. M. F acknowledges support from grant CNS2023-144436 funded by MICIU/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR” and from the European Commission (TBMED project, DT-NMBP-02-2018, grant agreement 814439)., Peer reviewed